
Homocysteine sits at a junction in methionine metabolism where vitamin B12, folate, vitamin B6 and kidney function all meet. That is what makes the number informative and also what makes it easy to misread as a cardiovascular target.
Homocysteine is one of the few blood markers that got hyped as a cardiovascular target, failed the trials that were built to test it, and then turned out to be genuinely useful for something else entirely. In a man over 40 it works as a functional readout of vitamin B12 and folate status, an early flag for declining kidney function, and the cheapest available screen for the B12 depletion that long term metformin use causes. What it is not is a number to chase with a B complex on the assumption that a lower value buys fewer heart attacks, because four large randomised trials tested exactly that assumption and it did not hold. This article covers the reference bands, the sample handling problem that makes many results wrong before they reach the lab, what the MTHFR C677T variant does and does not mean, and where the evidence for B vitamin supplementation is actually reasonable.
Homocysteine is an amino acid the body makes as a by-product of processing methionine from dietary protein. It is not consumed in food and it has no useful job of its own, which is why the body maintains two separate pathways for getting rid of it. Measuring homocysteine in a man over 40 is a way of asking whether both of those disposal routes are working, and the answer depends heavily on vitamin B12, folate, vitamin B6 and kidney function.
The reason the marker carries baggage is historical. Observational studies through the 1990s found that people with higher homocysteine had more cardiovascular events, and the natural conclusion was that lowering it with cheap B vitamins would lower risk. Between 2006 and 2010 four large randomised trials tested that idea in more than 40,000 people, lowered homocysteine substantially, and found no reduction in coronary events. The marker survived that failure because it turned out to be a good indicator of something other than what it was originally sold as.
Under 10
Generally Desirable
micromoles per litre, with most labs flagging above 15
10 to 15
Borderline Band
usually reflects B vitamin status rather than disease
10%/hour
False Rise In A Warm Tube
red cells keep releasing homocysteine before the sample is spun
0 events
Coronary Benefit In HOPE-2 And SEARCH
despite lowering homocysteine by 2 to 4 micromoles per litre
10 to 30%
Of Long Term Metformin Users
develop low vitamin B12, which raises homocysteine first
MMA
The Test That Separates B12 From Folate
methylmalonic acid rises only in B12 deficiency
What is homocysteine and why does it appear on a blood panel?
Homocysteine is an intermediate in the metabolism of methionine, an essential amino acid found in every protein a man eats. Methionine donates a methyl group to hundreds of reactions in the body, including DNA methylation and neurotransmitter synthesis, and homocysteine is what is left over after that donation. Blood concentration reflects the balance between how fast homocysteine is produced and how fast the two clearance pathways remove it.
The first clearance route is remethylation, which converts homocysteine back into methionine using a methyl group carried by folate and an enzyme, methionine synthase, that cannot function without vitamin B12. The second route is transsulphuration, which converts homocysteine into cystathionine and eventually cysteine using an enzyme that depends on vitamin B6. A shortage of B12, folate or B6 slows one of those routes, homocysteine backs up, and the concentration in blood rises. That is the entire logic of the test.
Input
Dietary Methionine
Protein in the diet supplies methionine, which is used as the body's universal methyl donor through S-adenosylmethionine, and homocysteine is the residue left after the methyl group has been handed off
Route 1
Remethylation, Needs B12 And Folate
Methionine synthase attaches a methyl group carried by 5-methyltetrahydrofolate back onto homocysteine, regenerating methionine. This enzyme requires vitamin B12 as a cofactor and stops working when B12 is low
Route 2
Transsulphuration, Needs B6
Cystathionine beta-synthase commits homocysteine irreversibly to cysteine production using vitamin B6 as a cofactor, which is the only route that genuinely removes homocysteine from the methionine cycle rather than recycling it
Backup
The Betaine Pathway
Betaine, also called trimethylglycine, can donate a methyl group through a separate liver enzyme independent of folate and B12, which is why betaine supplementation lowers homocysteine even when B vitamin status is adequate
Exit
Renal Clearance
The kidney handles a large share of homocysteine metabolism, which is why declining kidney function raises the number reliably and why an unexplained elevation should prompt a look at eGFR before anything else
What homocysteine level should a man over 40 want?
Below 10 micromoles per litre is generally considered desirable, 10 to 15 is a borderline band that usually reflects imperfect B vitamin status, and above 15 meets the common definition of hyperhomocysteinaemia. Many laboratories still print an upper reference limit near 15 because reference ranges are built from whatever the local population looks like, and in countries without folic acid fortification that population runs higher. A result of 13 will therefore be reported as normal by one lab and flagged by another.
Men run higher than women by roughly 1 to 2 micromoles per litre at the same age, and the number climbs steadily from the forties onward as kidney function and B12 absorption both decline. A value of 11 in a 55 year old man is unremarkable in the sense that plenty of his peers share it, and that is not the same as it being optimal. Values above 30 are uncommon and point toward significant renal impairment, severe B12 deficiency or a genetic disorder of the pathway, and belong with a physician rather than a supplement shelf.
How To Read A Homocysteine Result
| Result | Classification | What it usually reflects | Reasonable next step |
|---|---|---|---|
| Under 10 µmol/L | Desirable | B12, folate and B6 status are adequate and renal clearance is intact, and the marker is contributing nothing further to a risk picture | No action, and no reason to retest more than every couple of years |
| 10 to 15 µmol/L | Borderline | Most commonly marginal folate or B12 intake, sometimes heavy coffee intake, smoking or early kidney decline in a man in his fifties | Check serum B12 with methylmalonic acid, serum folate and eGFR before assuming a vitamin problem |
| 15 to 30 µmol/L | Moderate hyperhomocysteinaemia | Usually a genuine B12 or folate deficiency, chronic kidney disease, hypothyroidism, or the C677T variant combined with low folate intake | A physician workup that includes B12, methylmalonic acid, folate, thyroid function and kidney function |
| Above 30 µmol/L | Marked elevation | Advanced renal impairment, severe B12 deficiency including pernicious anaemia, or an inherited enzyme disorder | Clinical evaluation, not self management, since the underlying cause matters far more than the number |
| Any value from a mishandled sample | Uninterpretable | Blood left at room temperature before centrifugation, since red cells keep producing and releasing homocysteine into plasma after the draw | Repeat with a sample placed on ice and separated promptly, and ask the lab what its handling protocol is |
What actually raises homocysteine in a middle aged man?
In a man over 40 the three explanations that cover most elevated results are inadequate vitamin B12, inadequate folate, and reduced kidney function. Those are worth ruling in or out before anything more exotic gets considered. Vitamin B12 deficiency is particularly common with age because absorption depends on stomach acid and intrinsic factor, both of which decline, and because two widely used drug classes interfere with it directly.
Metformin reduces B12 absorption in the terminal ileum, and observational data puts the prevalence of low B12 in long term users somewhere between 10 and 30 percent depending on the threshold used. The American Diabetes Association recommends periodic B12 measurement in metformin-treated patients for this reason. Proton pump inhibitors taken for years produce a similar effect through a different mechanism, by suppressing the acid needed to liberate B12 from food protein. Neither of those is a reason to stop a prescribed medication, and both are reasons to know the number.
These proportions are an illustrative summary of the causes clinicians encounter rather than measured figures from a single cohort, and the mix shifts substantially with population. In countries that fortify flour with folic acid, folate deficiency accounts for a much smaller share than it does in countries that do not, and in an older or diabetic population the renal and B12 slices both grow. The pattern worth carrying is that a vitamin explanation and a kidney explanation are roughly equally likely in a man in his fifties, and only one of those is fixed by a supplement.
Does lowering homocysteine prevent heart attacks?
No. This is the clearest negative result in the whole marker literature and it deserves to be stated plainly. HOPE-2 randomised 5,522 patients with vascular disease or diabetes to folic acid, B6 and B12 or placebo, lowered homocysteine by 2.4 micromoles per litre, and found no reduction in death from cardiovascular causes or myocardial infarction. NORVIT, run in Norwegian heart attack survivors, found the same. SEARCH, which followed 12,064 myocardial infarction survivors for nearly seven years on folic acid and B12, found no effect on major vascular events.
The one signal that has survived meta-analysis is a modest reduction in stroke, on the order of 10 percent, driven largely by HOPE-2 and by trials conducted in populations without folic acid fortification. That is a real but small effect in a specific context, and it is not the finding the marker was originally promoted on. The broader lesson generalises past homocysteine. Moving a marker with an intervention that does not address the process the marker was tracking does not produce the outcome the association predicted, which is the same lesson niacin taught in the lipid field.
Does homocysteine matter for the brain?
The cognitive evidence is more interesting than the cardiovascular evidence and still falls well short of a recommendation. The VITACOG trial, published by Smith and colleagues in 2010, gave folic acid, B12 and B6 to 271 older adults with mild cognitive impairment for two years and measured brain volume on serial MRI. The rate of atrophy fell by roughly 30 percent overall and by around 53 percent in participants whose baseline homocysteine was above 13 micromoles per litre.
Two caveats sit on top of that result. A later analysis found the benefit was largely confined to participants with adequate omega-3 status, suggesting the pathway needs more than B vitamins to matter, and brain volume on MRI is a surrogate for cognitive decline rather than the thing itself. VITACOG has also not been replicated at scale. What it supports is measuring homocysteine in an older man with genuine cognitive complaints and correcting a deficiency if one is found, which is a narrower claim than the supplement industry makes from the same data.
This curve illustrates the shape and rough magnitude of the response seen when a genuine deficiency is corrected, not measured data from one trial. Most of the fall happens inside the first four to six weeks and the curve then flattens, which is why a repeat draw at eight to twelve weeks is informative and a repeat at three weeks mostly is not. A man whose homocysteine was elevated for a renal reason rather than a vitamin reason will see almost none of this movement, and that non-response is itself a useful piece of information.
What does the MTHFR C677T variant actually mean?
The C677T variant in the MTHFR gene produces a version of the enzyme that is less thermostable and works less efficiently, which raises homocysteine modestly when folate intake is low and barely at all when folate intake is good. Roughly 10 percent of people of European ancestry carry two copies, with the frequency varying widely by population, and homozygous carriers with poor folate status average around 20 percent higher homocysteine than non-carriers.
The variant became a fixture of direct-to-consumer genetic reports and of a small industry selling methylfolate on the strength of it, which outran the evidence considerably. Mendelian randomisation studies using C677T as a natural experiment have generally not found the coronary risk the observational homocysteine data predicted, which was one of the earlier signs that the cardiovascular hypothesis was wrong. There is one genuinely specific finding worth knowing: riboflavin, vitamin B2, lowers homocysteine in C677T homozygotes specifically, because riboflavin is the cofactor the weakened enzyme struggles to hold on to. Doses around 1.6 milligrams daily were used in the Irish trials that showed it.
Do metformin, GLP-1 medications or testosterone change homocysteine?
Metformin does, indirectly and reliably, by reducing vitamin B12 absorption over years of use. A man who has taken metformin for five years and has a homocysteine of 14 has a plausible mechanistic explanation sitting in his medicine cabinet, and the appropriate response is a B12 and methylmalonic acid measurement rather than a guess. GLP-1 receptor agonists have no established direct effect on homocysteine, though the substantial reduction in food intake they produce can lower folate and B12 intake enough to matter in a man eating very little.
The testosterone link is weak and mostly observational. Cross-sectional studies have reported an inverse association between testosterone and homocysteine in men, and the direction of causation is not established, since low testosterone travels with visceral adiposity, insulin resistance and reduced kidney function, all of which have their own relationships with homocysteine. No trial has shown that treating one changes the other in a way that matters clinically. Testosterone therapy is a prescription treatment and no man should approach it as a lever for a B vitamin marker.
How should the test be drawn and interpreted?
Sample handling matters more for homocysteine than for almost any other routine marker, and it is where a large share of confusing results originate. Red blood cells continue producing and releasing homocysteine into the plasma after the blood is drawn, at a rate that can add roughly 10 percent per hour while the tube sits at room temperature. A sample that waits two hours before centrifugation can read meaningfully higher than the same blood spun immediately. Ask whether the sample will be chilled and separated promptly, and treat a surprising result from a courier-collected draw with suspicion.
Order B12 with methylmalonic acid, not B12 alone
Serum B12 is a poor test with a wide indeterminate zone, and a man can be functionally deficient with a serum value inside the reference range. Methylmalonic acid rises in B12 deficiency and not in folate deficiency, which is what separates the two causes that homocysteine cannot distinguish on its own
Look at kidney function before assuming a vitamin problem
The kidney handles a large share of homocysteine metabolism, so an elevated result in a man over 50 warrants a look at eGFR and cystatin C. Treating a renal elevation with a B complex produces no change in the number and delays the finding that mattered
Review long term medications
Metformin and proton pump inhibitors both deplete B12 over years through separate mechanisms. Neither should be stopped over a blood marker, and both make periodic B12 monitoring reasonable in anyone taking them long term
Correct the deficiency, do not chase the number
If B12 or folate is genuinely low, correcting it is worth doing on its own merits, since B12 deficiency causes neuropathy and cognitive symptoms that do not fully reverse if left long enough. The homocysteine value is the signal, not the target
Check thyroid function if nothing else fits
Hypothyroidism raises homocysteine and is easy to miss in a middle aged man whose fatigue gets attributed to age or to low testosterone. A TSH and free T4 cost very little and rule out a cause that no supplement addresses
Retest at eight to twelve weeks, once
Most of the response to a corrected deficiency occurs inside the first six weeks. One follow-up draw confirms whether the intervention did anything, and a man who is still testing homocysteine quarterly two years later has turned a diagnostic into a hobby
Week 1: Get a usable number
Weeks 2 to 4: Find the cause, not the fix
Weeks 4 to 12: Correct what is actually low
Month 3 onward: Confirm and stop
So is homocysteine worth adding to a panel?
Homocysteine is worth measuring once in a man over 40, and worth measuring periodically in a man on long term metformin or a proton pump inhibitor, in a man with reduced kidney function, or in a man with genuine cognitive complaints. It is a cheap functional test that catches B12 and folate problems earlier and more sensitively than serum B12 alone, and it flags kidney decline that a creatinine on its own can miss. Those are real uses.
What homocysteine is not is a cardiovascular target. Four large trials lowered it substantially and did not reduce coronary events, and no amount of mechanistic plausibility overturns that. A man who finds a value of 13 and starts a methylfolate protocol on the strength of a genetic report has skipped every question that would have made the result useful, starting with whether his kidneys are the reason. The number is a prompt to look for a cause, and the cause is what gets treated.
Medical Disclaimer
This article is for educational purposes only and is not medical advice. Nothing here diagnoses, treats, cures or prevents any disease or condition, including cardiovascular disease, stroke, dementia, pernicious anaemia, chronic kidney disease or hypogonadism. Metformin, proton pump inhibitors and testosterone are prescription products discussed here only in terms of what published research has measured, and no one should start, stop or alter a prescribed medication on the basis of a blood marker. Vitamin B12 deficiency can cause irreversible neurological injury and its investigation and treatment belong with a physician, particularly because high dose folic acid can mask it. The charts in this article are illustrative representations of direction, relative magnitude and physiological pattern rather than measured trial results, and the studies referenced differ in population, intervention, duration and endpoint, so their figures are not directly comparable to one another.
Continue Reading
hs-CRP in Men Over 40: The Inflammation Marker Most Blood Panels Leave Off
11 min read
Vitamin D, Zinc, and Magnesium: The Floor Under Your Testosterone
11 min read
Berberine vs Metformin for Men Over 40: What the Head to Head Data Actually Shows
13 min read